Evidence map›Paper›PMID 25486532›Full record

ArticlePloS one2014

Phosphorylation of ribosomal protein S6 kinase 1 at Thr421/Ser424 and dephosphorylation at Thr389 regulates SP600125-induced polyploidization of megakaryocytic cell lines.

Chang-Ling Li, Jin-Gang Yang, Di Lin, Yong-Shan Zhao, Shuo Liu, Si-Ning Xing, Song Zhao, Cong-Qin Chen, Zhi-Ming Jiang, Fei-Fei Pu and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chang-Ling LiDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Jin-Gang YangDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Di LinDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Yong-Shan ZhaoSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenhe District, Shenyang, Liaoning, China.
Shuo LiuDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Si-Ning XingDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Song ZhaoDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Cong-Qin ChenClinical Pharmacy, Shenyang Pharmaceutical University, Shenhe District, Shenyang, Liaoning, China.
Zhi-Ming JiangDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Fei-Fei PuDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Jian-Ping CaoDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
Dong-Chu MaDepartment of Experimental Medicine, General Hospital of Shenyang Military Area Command, Shenhe District, Shenyang, Liaoning, China.
General Hospital of Shenyang Military Region · CNShenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Megakaryocytes (MKs) are one of the few cell types that become polyploid; however, the mechanisms by which these cells are designated to become polyploid are not fully understood. In this investigation, we successfully established two relatively synchronous polyploid cell models by inducing Dami and CMK cells with SP600125. We found that SP600125 induced the polyploidization of Dami and CMK cells, concomitant with the phosphorylation of ribosomal protein S6 kinase 1 (S6K1) at Thr421/Ser424 and dephosphorylation at Thr389. The polyploidization was partially blocked by H-89, a cAMP-dependent protein kinase (PKA) inhibitor, through direct binding to S6K1, leading to dephosphorylation at Thr421/Ser424 and phosphorylation at Thr389, independent of PKA. Overexpression of a rapamycin-resistant mutant of S6K1 further enhanced the inhibitory effect of LY294002 on the SP600125-induced polyploidization of Dami and CMK cells. SP600125 also induced the polyploidization of Meg-01 cells, which are derived from a patient with chronic myelogenous leukemia, without causing a significant change in S6K1 phosphorylation. Additionally, SP600125 induced the polyploidization of HEL cells, which are derived from a patient with erythroleukemia, and phosphorylation at Thr389 of S6K1 was detected. However, the polyploidization of both Meg-01 cells and HEL cells as a result of SP600125 treatment was lower than that of SP600125-induced Dami and CMK cells, and it was not blocked by H-89 despite the increased phosphorylation of S6K1 at Thr389 in both cell lines in response to H-89. Given that the Dami and CMK cell lines were derived from patients with acute megakaryocytic leukemia (AMKL) and expressed high levels of platelet-specific antigens, our data suggested that SP600125-induced polyploidization is cell-type specific, that these cell lines were more differentiated, and that phosphorylation at Thr421/Ser424 and dephosphorylation at Thr389 of S6K1 may play an important role in the SP600125-induced polyploidization of these cell lines synergistically with other signaling pathways.

Indexed as

AnthracenesCell LineCell ProliferationCyclic AMP-Dependent Protein KinasesDose-Response Relationship, DrugHumansIsoquinolinesMegakaryocytesModels, MolecularMolecular ConformationMutationPhosphorylationPolyploidyProtein BindingProtein Interaction Domains and MotifsProtein Kinase InhibitorsAnthracenesCyclic AMP-Dependent Protein KinasesIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideProtein Kinase Inhibitorspyrazolanthroneribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaSulfonamides

Identifiers

PMID25486532
PMCPMC4259319
OpenAlexW1973738336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.